Literature DB >> 1672321

Penicillin-resistant pneumococci.

K D Allen1.   

Abstract

Penicillin-resistant pneumococci were first reported in Australia in 1967 and appeared in the UK in 1976. Their prevalence is increasing but varies greatly worldwide. The mechanism of resistance lies in the alteration of penicillin-binding proteins. Penicillin-resistant strains are often also resistant to a variety of non-beta-lactam antibiotics. Many different serotypes have been found to be penicillin resistant, type 23 being the most common resistant serotype in the UK. Use of oxacillin discs is recommended for penicillin sensitivity testing, otherwise resistant isolates may escape detection. Treatment of infected patients depends on several factors including the degree of resistance of the infecting strain, the sensitivity to alternative agents and the achievable concentration of antibiotic at the site of the infection. Carriage of penicillin-resistant pneumococci is more common in children, especially the recently hospitalized and those recently exposed to antibiotics. Outbreaks of infection have occurred and various control measures have been suggested in attempts to limit the spread of resistant strains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672321     DOI: 10.1016/0195-6701(91)90072-g

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992.

Authors:  J F Sessegolo; A S Levin; C E Levy; M Asensi; R R Facklam; L M Teixeira
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

3.  Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.

Authors:  C Sauve; E Azoulay-Dupuis; P Moine; C Darras-Joly; V Rieux; C Carbon; J P Bédos
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

4.  Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway.

Authors:  T Magnus; B M Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

5.  Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.

Authors:  R F Jacobs; S L Kaplan; G E Schutze; A S Dajani; R J Leggiadro; C S Rim; S K Puri
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA.

Authors:  O M Ige; A O Okesola
Journal:  Ann Ib Postgrad Med       Date:  2015-12

7.  Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

Authors:  Vindu Amitabh; Anish Singhal; Sudhir Kumar; Narmada Patel; Yasir S Rizvi; Pankaj Mishra
Journal:  Lung India       Date:  2012-07

8.  Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran.

Authors:  Samira Habibian; Ali Mehrabi-Tavana; Zyanab Ahmadi; Morteza Izadi; Nematolah Jonaidi; Jalalodin Darakhshanpoure; Mahmode Salesi; Seyed Mohsen Zahraei; Ramezan Ali Ataee
Journal:  Iran Red Crescent Med J       Date:  2013-10-05       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.